Beam Therapeutics (BEAM) Change in Accured Expenses (2019 - 2026)
Beam Therapeutics (BEAM) reported Change in Accured Expenses of -$16.3 million for Q1 2026, up 11.92% year-over-year from -$14.5 million in Q1 2025, and down 213.71% on a QoQ basis from $14.3 million in Q4 2025.
Beam Therapeutics (BEAM) has 8 years of Change in Accured Expenses data on file, last reported at -$16.3 million in Q1 2026.
- Quarterly Change in Accured Expenses rose 11.92% year-over-year to -$16.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.9 million (up 119.06% YoY) and the FY2025 annual result came in at $7.7 million, up 113.32% from the prior year.
- Change in Accured Expenses slipped to -$16.3 million in Q1 2026 per BEAM's latest filing, from $14.3 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $70.4 million in Q4 2023 and bottomed at -$24.3 million in Q1 2024.
- The 5-year median for Change in Accured Expenses is -$266000.0 (2023), against an average of $38411.8.
- The widest annual swing landed in 2023, when Change in Accured Expenses jumped 733.84%; it then tumbled 7225.56% in 2024.
- Tracing BEAM's Change in Accured Expenses over 5 years: stood at $8.4 million in 2022, then jumped by 733.84% to $70.4 million in 2023, then slumped by 105.79% to -$4.1 million in 2024, then surged by 450.87% to $14.3 million in 2025, then sank by 213.71% to -$16.3 million in 2026.
- Per Business Quant, the three latest BEAM Change in Accured Expenses figures stand at -$16.3 million (Q1 2026), $14.3 million (Q4 2025), and $2.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Beam Therapeutics | 3.40 Bn | 3.40 Bn | - | -16.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.26 Mn |
| Mar 31, 2026 | -16.26 Mn |
| Dec 31, 2025 | 14.30 Mn |
| Dec 31, 2025 | 14.30 Mn |
| Sep 30, 2025 | 1.98 Mn |
| Sep 30, 2025 | 1.98 Mn |
| Jun 30, 2025 | 9.87 Mn |
| Jun 30, 2025 | 9.87 Mn |
| Mar 31, 2025 | -18.46 Mn |
| Mar 31, 2025 | -18.46 Mn |
| Dec 31, 2024 | -4.08 Mn |
| Dec 31, 2024 | -4.08 Mn |
| Sep 30, 2024 | -9.85 Mn |
| Sep 30, 2024 | -9.85 Mn |
| Jun 30, 2024 | -19.49 Mn |
| Jun 30, 2024 | -19.49 Mn |
| Mar 31, 2024 | -24.28 Mn |
| Mar 31, 2024 | -24.28 Mn |
| Dec 31, 2023 | 70.40 Mn |
| Dec 31, 2023 | 70.40 Mn |
| Sep 30, 2023 | 7.42 Mn |
| Sep 30, 2023 | 7.42 Mn |
| Jun 30, 2023 | -266,000.00 |
| Jun 30, 2023 | -266,000.00 |
| Mar 31, 2023 | -9.89 Mn |
| Mar 31, 2023 | -9.89 Mn |
| Dec 31, 2022 | 8.44 Mn |
| Dec 31, 2022 | 8.44 Mn |
| Sep 30, 2022 | 3.94 Mn |
| Sep 30, 2022 | 3.94 Mn |
| Jun 30, 2022 | 3.40 Mn |
| Jun 30, 2022 | 3.40 Mn |
| Mar 31, 2022 | -16.53 Mn |
| Mar 31, 2022 | -16.53 Mn |
| Dec 31, 2021 | 41.10 Mn |
| Dec 31, 2021 | 41.10 Mn |
| Sep 30, 2021 | 1.17 Mn |
| Sep 30, 2021 | 1.17 Mn |
| Jun 30, 2021 | 6.11 Mn |
| Jun 30, 2021 | 6.11 Mn |
| Mar 31, 2021 | -4.46 Mn |
| Mar 31, 2021 | -4.46 Mn |
| Dec 31, 2020 | 2.82 Mn |
| Dec 31, 2020 | 2.82 Mn |
| Sep 30, 2020 | 4.46 Mn |
| Sep 30, 2020 | 4.46 Mn |
| Jun 30, 2020 | -617,000.00 |
| Jun 30, 2020 | -617,000.00 |
| Mar 31, 2020 | 378,000.00 |
| Mar 31, 2020 | 378,000.00 |
| Dec 31, 2019 | 2.20 Mn |
| Dec 31, 2019 | 2.20 Mn |
| Sep 30, 2019 | -50,000.00 |
| Sep 30, 2019 | -50,000.00 |
| Jun 30, 2019 | 2.02 Mn |
| Jun 30, 2019 | 2.02 Mn |
| Mar 31, 2019 | -595,000.00 |
| Mar 31, 2019 | -595,000.00 |